CORT - Corcept Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CORT is currently covered by 4 analysts with an average price target of $106.11. This is a potential upside of $18.12 (20.59%) from yesterday's end of day stock price of $87.99.

Corcept Therapeutics's activity chart (see below) currently has 102 price targets and 83 ratings on display. The stock rating distribution of CORT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 89.63% with an average time for these price targets to be met of 259.18 days.

Highest price target for CORT is $145, Lowest price target is $131, average price target is $138.67.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 25-Nov-2025. First documented stock forecast 12-Oct-2015.

Currently out of the existing stock ratings of CORT, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$145

$65.6 (82.62%)

$145

18 days ago
(25-Nov-2025)

15/22 (68.18%)

$64.72 (80.62%)

134

Buy

$140

$60.6 (76.32%)

$140

2 months 18 days ago
(25-Sep-2025)

7/11 (63.64%)

$57.27 (69.23%)

325

Buy

$131

$51.6 (64.99%)

$78

8 months 10 days ago
(03-Apr-2025)

7/8 (87.5%)

$51.63 (65.05%)

86

Buy

$38

$13.94 (57.94%)

$29

2 years 1 months 8 days ago
(06-Nov-2023)

2/3 (66.67%)

$12.09 (46.66%)

37

Hold

$29

$-50.4 (-63.48%)

$26

2 years 4 months 10 days ago
(03-Aug-2023)

4/4 (100%)

$-2.24 (-7.17%)

262

Show more analysts

Please expand the browser size to see the chart

What is CORT (Corcept Therapeutics) average time for price targets to be met?

On average it took 259.18 days on average for the stock forecasts to be realized with a an average price target met ratio 89.63

Which analyst has the current highest performing score on CORT (Corcept Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the most public recommendations on CORT (Corcept Therapeutics)?

Edward Nash works at CANACCORD and has 3 price targets and 3 ratings on CORT

Which analyst is the currently most bullish on CORT (Corcept Therapeutics)?

Swayampakula Ramakanth with highest potential upside - $65.6

Which analyst is the currently most reserved on CORT (Corcept Therapeutics)?

David Buck with lowest potential downside - -$68.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?